1. Home
  2. NKTX vs ARAY Comparison

NKTX vs ARAY Comparison

Compare NKTX & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$1.81

Market Cap

147.7M

Sector

Health Care

ML Signal

HOLD

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$1.03

Market Cap

170.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
ARAY
Founded
2015
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.7M
170.1M
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
NKTX
ARAY
Price
$1.81
$1.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$13.25
$4.50
AVG Volume (30 Days)
684.9K
1.2M
Earning Date
11-10-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$450,902,000.00
Revenue This Year
N/A
$5.70
Revenue Next Year
N/A
$4.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.51
52 Week Low
$1.31
$0.91
52 Week High
$3.16
$2.95

Technical Indicators

Market Signals
Indicator
NKTX
ARAY
Relative Strength Index (RSI) 40.37 35.59
Support Level $1.77 $0.99
Resistance Level $1.93 $1.12
Average True Range (ATR) 0.09 0.07
MACD 0.01 0.02
Stochastic Oscillator 30.00 40.33

Price Performance

Historical Comparison
NKTX
ARAY

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Share on Social Networks: